Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alcon
Biotech
Alcon’s $770M Aerie takeover delivers phase 3 dry eye wins
The lead candidate in the acquired pipeline met the primary phase 3 endpoint, positioning Alcon to file for FDA approval in the middle of the year.
Nick Paul Taylor
Jan 10, 2024 5:40am
Alcon reaches $199M settlement with J&J Vision
Feb 13, 2023 2:15pm
Alcon, J&J settle for $75M in contact lens price-fixing case
Oct 14, 2022 2:07pm
Alcon swoops on Aerie, striking $770M buyout to expand pipeline
Aug 23, 2022 7:45am
Alcon scopes out $475M acquisition of Ivantis
Nov 8, 2021 10:10am
LENZ eyes FDA submission with $47M in fresh funds, new CEO
Jun 17, 2021 10:34am